Upload
evan-oconnor
View
232
Download
1
Tags:
Embed Size (px)
Citation preview
Paracetamol and Aspirin Paracetamol and Aspirin PoisoningPoisoning
Dr. SH TsuiDr. SH Tsui
23 March 200523 March 2005
ParacetamolParacetamol
• Very Common– 1054 registered pharmaceuticals
contain paracetamol in HK
• Perceived to be benign– But it can be lethal
• Treatable– Early antidote
Poisoning DataPoisoning Data
• Local – UCH database– About 1000 cases– Paracetamol 16%
• US - TESS 2002– 2.3 million exposure– Analgesics 10.8%– Paracetamol 4.9%– Salicylates 0.8%
QMH dataQMH data
• May to October 1998
• Total cases of DO: 205
• Paracetamol involved: 33 (16%)
• Mortality: nil
• Paracetamol found without a history of intake: 4
• With potentially toxic level: 1 out of 4
Who will manage this case in Who will manage this case in A&E/Observation ward?A&E/Observation ward?
• Young lady taken 12 tabs of panadol 3 hours ago?
• Young man taken 20 tabs of panadol half an hour ago?
• Paracetamol level at 4hr came back to be 896mol/L, LFT normal
Who will continue to manage?
Who will start NAC?• Who will give full course of NAC in their O ward?
PharmacokineticsPharmacokinetics
• Potential toxic dose– >150mg/kg
• Rapid absorption– Peak within 1-2 hour
• Vd – 1L/kg
• T1/2
– 2-3 hours, – Increased in overdose
Metabolism Metabolism
• Non toxic metabolites– Sulfate conjugate– Glucuronide conjugate
• Toxic metabolites– NAPQI
• Determinants– Dose– P450 activity– 2E1 – polymorphism
results in different susceptibility
– Glutathione
APAPSulfateGlucuronide
>90%
Urine (unchanged)
cytochromeP450 (IIE1, IA2, IIIA4)
NAPQIGlutathione depletedGlutathione
Mercapturic acid conjugates
Cell Damage
Liver toxicityLiver toxicity
• Central zone– Highest
concentration of P450
– Lowest oxygen content
• Massive centrilobular necrosis
Risk factors for liver toxicityRisk factors for liver toxicity
• Enzyme induction: smoking, barbituates, phentoin, isoniazids, ethanol
• Decreased glutathione store: malnutrition-alcoholism, HIV, chronic illness
Renal toxicityRenal toxicity
– Consistent with acute tubular necrosis
– P 450 in kidney
– NAPQI formation– Not hepato-renal
initially
In massive overdoseIn massive overdose
• CNS– Coma – P450 in brain, ? Mechanism
• Metabolic– Metabolic acidosis, mitochondria dysfunction
• Coagulopathy– Directly interfere with coagulation factors– Later 2o to liver failure
Clinical PresentationClinical Presentation
I 0.5-24
Hours
Nausea, vomiting, anorexia, pallor, or entirely normal appearance
II 18-72
Hours
Progressive laboratory and clinical signs of hepatic injury
III 72-96
Hours
Hepatic failure
Multi-organ failure
IV 4 to 14
Days
Recovery or death
Liver is entirely normal after recovery
Must Screen LevelMust Screen Level
• Paracetamol level– Approximately 1/500 poisoned cases
where there is no history of paracetamol overdose has a level requiring therapy
– Cost effectiveAshbourne: Ann Emerg Med 1989:18:1035
Kulig: Ann Emerg Med 1985;14:562
Sporer KA, Am J Emerg Med.1996;14:443-6
TreatmentTreatment
• GI decontamination• Antidote• Liver failure
– Supportive– Transplant
GI decontaminationGI decontamination
• Early (< 4 hours)– Activated charcoal – GL for co-ingestion only
• Late– No indication for decontamination in
pure overdose– Activated charcoal consideration in
mixed overdose
Natural History of Untreated OverdoseNatural History of Untreated Overdose
Mortality < 5%
Hepatic failure 5-10%
Clinical hepatitis 20-40%
Chemical hepatitis 50-70%
Renal failure 10%
Efficacy of NACEfficacy of NAC
– <8 hours - no morbidity and mortality – 8- 24 hours, 10-30% had AST>1000
Smilkstein: N Engl J Med 1988;319:1557
– 10-36 hours, reduce mortality in fulminant hepatic failure
(58% Vs 37%)Harrison: Lancet. 1990 Jun 30;335(8705):1572-3
– 36-80 hours, reduce mortality
(48% Vs 20%) Keays: Brit Med J 1991;303:1026
Smilkstein: N Engl J Med 1988;319:1557
Antidote : N-acetylcystecineAntidote : N-acetylcystecine
• Mechanism of action in early phase– Major
• Increases non-toxic sulfation• Precursor for glutathione
– Minor • Directly conjugates NAPQI• Directly reduces NAPQI back to
Paracetamol
Antidote : N-acetylcystecineAntidote : N-acetylcystecine
• Mechanism of action in late phase– Non-specific antioxidant– Impairs WBC migration to injury – Improves hepatic oxygen extraction
Harrison: N Engl J Med 1991;324:1852
– Improves cardiac outputHarrison: N Engl J Med
1991;324:1852
Indications for NAC TherapyIndications for NAC Therapy
– Level available < 8 hours• Wait for level• Treat if above nomogram
– Level not available < 8 hours post ingestion • Treat first• Make decision to continue or stop therapy based on level
– Late Presentation (>24 hrs post-ingestion)• Detectable paracetamol level• Elevated AST
– Fulminant liver failure
NomogramNomogram
• Paracetamol (g/ml) = 0.15 x Paracetamol (mol/L)
Drawbacks of NormogramDrawbacks of Normogram
• Refers to single acute ingestion
• Applicability to young children never been proved
• Time of ingestion not always accurate in real life situation
• Does not predict life or death
IV NAC doseIV NAC dose• 150mg/kg in 200ml D5 over 1 hour
then• 50mg/kg in 500ml D5 over 4 hours
then• 100mg/kg in 1000ml D5 over 16
hours
• Total dose 300mg/kg in 21 hours
• Rate-related side effectAnaphylactoid reactionRash, utricaria, bronchospasm, hypotension
Treatment of liver failureTreatment of liver failure
• Supportive treatment– NAC
• 150mg/kg every 24 hours till death or recovery
– Plasmapheresis– Bioartificial Liver (BAL)
• Liver transplants– 50% survival in 10 years– Clinical Predictors
Predictors of death in Paracetamol Predictors of death in Paracetamol liver failureliver failure
• Kings College’s criteria• pH < 7.30 after volume
resuscitation OR • Combination of 3 parameters
– Stage III or IV encephthalopathy– PT > 100 seconds– Creatinine above 300µmol/L
O’Grady: Gastroenterology 1989:97:439
• Newer Predictors– Lactate– Phosphate
Extended Release PreparationsExtended Release Preparations
• First marketed in 1994
• Bilayered preparation contains ~650mg of paracetamol
• Delayed dissolution and release of half of the drug
Observations from case reportsObservations from case reports
• 13 patients with overdose of ER formulation
• Elimination phase was delayed in 8 patients
• 3 patients had non-toxic levels at 4hr subsequently had levels in toxic range
Cetaruk: Ann Emerg Med 1997; 30: 104-8
RecommendationsRecommendations
• Check levels at 4 hour and then 4-6hrs later
• NAC if either value is above treatment line
• If 2nd level> 1st level, or lies close to toxic range, start NAC and obtain additional measurements
Temple: N Eng J Med. 1995; 333: 1058-9
How about Fast Acting How about Fast Acting Paracetamol?Paracetamol?
• Paracetamol & sodium bicarbonate
• Doubles the absorption rates
• Syrup panadol overdose (Also fast absorption)
Repeated Supra-therapeutic Repeated Supra-therapeutic intakeintake
• >4gm for 24hr or more
• >90mg/kg/day for 24hr or more
• GI decontamination not a priority
• Normogram not applicable
• NAC if detectable paracetamol level or elevated liver enzyme
• Continue NAC until 24hrs after last dose or improvement of patient
Summary – ParacetamolSummary – Paracetamol
• Common overdose• No clear early toxidrome• Must screen with level• Early therapy very effective • Late therapy still efficacious• Identify high risk patients for
transfer to liver transplant unit
SalicylatesSalicylates
• Common anti-inflammatory, analgesic, antipyretics, and anti-platelet agent– 57 and 132 registered pharmaceuticals in
HK contain aspirin and salicylate
• Different preparations– Aspirin (acetyl salicylic acid) tablets– Enteric coated– Topical Preparations (methyl salicylate)
• Dangerous -7gm of salicylate in 5 ml
PharmacokineticsPharmacokinetics
• Absorption– Tablets dissolution is the rate
determining step– Formation of concretion– Pyloric spasm– Significant dermal absorption,
especially in diseased skinBrubacher JR: J tox clin tox 1996; 34(4):431-6
• Distribution– High protein-bound
• saturated in overdose
– Vd -0.15 → 0.35 L/kg– pH effect
• Weak acid. pKa 3
pH effectpH effect
• Acidemia • pH in serum lower than that of CSF
• Alkalemia • pH of serum higher than that of CSF
• HA Can cross membrane
• H+ A- Cannot cross membrane
pH ↑ pH ↓
Metabolism & ExcretionMetabolism & Excretion
• Therapeutic– Hepatic conjugation with glucuronic acid or
glycine– Renal elimination insignificant
• Overdose– Hepatic conjugation saturated– Renal elimination become important
PathophysiologyPathophysiology
• Uncouple the oxidative phosphorylation– Short circuit the
mitochondria membrane potential
– Generate heat instead
• Inhibits dehydrogenase in Kreb’s cycle
HA
H+A-
X
Clinical ManifestationClinical Manifestation
CNS – Tinnitus or hearing
impairment – Confusion, lethargy,
coma, seizure– Cerebral edema– Death
Clinical ManifestationClinical Manifestation
• Acid/Base– Early respiratory alkalosis
• Hyperventilation by ↑RR or/and ↑TV
– Mixed metabolic acidosis and respiratory alkalosis
• Lactates, ketones and salicylates
– Acidemia – decompensate and dying
• pH < 7.4 – poor prognostic maker
pH PCO2 mmHG
HCO- mmol/L
Early 7.5 30 24
Later 7.4 30 20
Dying 7.3 45 20
Dying 7.3 30 16
Clinical ManifestationClinical Manifestation
• GI - Vomiting• Pulmonary – ALI • CVS – Tachycardia• Hyperthermia• Sweating• Hypokalemia• Glucose
Diagnosis & Severity assessmentDiagnosis & Severity assessment• History
– >150mg/kg
• Clinical manifestation - most important !– Subtle in chronic poisoning (30% misdiagnosis)
• FeCl3 test
• ABG, electrolytes, urinalysis• Drug level
– Therapeutic 15-30mg/dl– Serum Salicylates (mg/dL)=13.8x serum
salicylates (mmol/L)– Serial trend
Done NomogramDone Nomogram
• Limitation– Assume all cases had
a same pH – Clinically NOT useful
ManagementManagement
• GI decontamination
• ABC
• Alkalinization
• Extracorporeal removal
GI decontaminationGI decontamination
• Gastric lavage– Acute large overdose– Spontaneous vomiting is common
• Multiple dose activated charcoal– Reduce delayed absorption
• Whole Bowel Irrigation for enteric coated tablets
ABCABC• DO NOT allow
respiratory acidosis during and following intubation
• Kill the patient quickly
• DO give aggressive volume resuscitation
• Hypovolemia– Vomiting– Sweating– Fever– Hyperpnea
ABCABC
• Monitor blood glucose and correct hypoglycaemia
• Maintain a high normal blood glucose• Maintenance IV Fluid: 1L D5
40 mmol KCL
3 amp of NaHCO3• Adjust infusion rate and concentration• Monitor urine output, serum/urine pH and serum
K level
AlkalinizationAlkalinization• Aim for both serum & urine alkalinization• Indications
– Clinical Salicylism– Level > 40mg/dl
• NaHCO3
– Bolus 1-2mEq/kg– Maintenance
• Goal – Urine pH 7.5-8– Serum pH 7.45-7.55
• K+ is important for success
Extracorporeal removalExtracorporeal removal
• Indications– Vital end-organs toxicity– Failure of excretion– Failure of conservative
management– Level
• Acute > 100mg/dl• Chronic >60mg/dl
• Methods– Hemodialysis– Charcoal hemoperfusion– Hemodialysis in series with
hemoperfusion– Exchange transfusion in
infants
Are you going to manage this Are you going to manage this case?case?
• F20, Ingested 1 pack of Cortal® 3 hours ago
• C/O Nausea, otherwise asymptomatic
• Amount of ingestion (Assume 50kg): 200mg/kg
• Range of mild to moderate toxicity
Summary - AspirinSummary - Aspirin
• Another common overdose• Understand the pharmacokinetic• Recognize the clinical manifestation
and how to assess the severity• Nomogram NOT useful clinically• Don’t allow acidemia• Treatment options available
and their indications
Thank you !Thank you !
Dinner timeDinner time